Dieter Mayer:As head of wound care, University Hospital Zürich I come across the challenges of leg/foot tissue loss on a daily basis. My personal ambition for ilegx is to provide simple and powerful interdisciplinary pathways that help chronic wound patients to reduce their burden.
Gunnar Tepe:Everybody agrees that an effective management of leg/tissue loss requires an interdisciplinary team effort but has such an interdisciplinary approach been really established to date. Personally I feel that too many patients are still left out or seen either by the wrong person or even too late. Ilegx aims to develop understanding and cooperation between the involved disciplines - a truly inspirational venture from my point of view.
Michael Edmonds:Based on our work with the Eurodiale Group we discovered that treatment of many diabetic foot patients is not in line with current guidelines. Current guidelines apear to be too general and healthcare organizational barriers and personal beliefs result in underuse of recommended therapies. Therefore I would like to act on overcoming these barriers in order to guarantee the delivery of optimal care for the many individuals with diabetic foot disease.
